Income Taxes (Tables)
|
12 Months Ended |
Jan. 25, 2026 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income Tax Expense |
The Income tax expense applicable to income before income taxes consists of the following: | | | | | | | | | | | | | | | | | | | | Year Ended | | | Jan 25, 2026 | | Jan 26, 2025 | | Jan 28, 2024 | | | | | | | | | (In millions) | | Current income taxes: | | | | | | | Federal | $ | 19,039 | | | $ | 14,032 | | | $ | 5,710 | | | State | 1,218 | | | 892 | | | 335 | | | Foreign | 2,550 | | | 699 | | | 502 | | | Total current | 22,807 | | | 15,623 | | | 6,547 | | | Deferred income taxes: | | | | | | | Federal | (1,364) | | | (4,515) | | | (2,499) | | | State | (885) | | | (242) | | | (206) | | | Foreign | 825 | | | 280 | | | 216 | | | Total deferred | (1,424) | | | (4,477) | | | (2,489) | | | Income tax expense | $ | 21,383 | | | $ | 11,146 | | | $ | 4,058 | |
|
| Schedule of Income Before Income Tax |
Income before income tax consists of the following: | | | | | | | | | | | | | | | | | | | | Year Ended | | | Jan 25, 2026 | | Jan 26, 2025 | | Jan 28, 2024 | | | | | | | | | (In millions) | | U.S. | $ | 123,181 | | | $ | 77,456 | | | $ | 29,495 | | | Foreign | 18,269 | | | 6,570 | | | 4,323 | | | Income before income tax | $ | 141,450 | | | $ | 84,026 | | | $ | 33,818 | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21.0% to income before income taxes for the fiscal year ended January 25, 2026 as follows: | | | | | | | | | | | | | | | | | | | | | | Year Ended | | | Jan 25, 2026 | | | | | | | | | | | | | | | | | | | (In millions, except percentages) | US Federal Statutory Tax Rate | $ | 29,704 | | | 21.0 | % | | | | | | | | |
| | | | | | | | | | | | | State and Local Income Taxes, Net of Federal Income Tax Effect (1) | 258 | | | 0.2 | % | | | | | | | | | | Foreign tax effects | | | | | | | | | | | | | Israel | | | | | | | | | | | | Reduced statutory tax rate on qualifying income | (3,064) | | | (2.2) | % | | | | | | | | | Other | 1,606 | | | 1.2 | % | | | | | | | | | Other foreign jurisdictions | 741 | | | 0.5 | % | | | | | | | | | | Effect of cross-border tax laws | | | | | | | | | | | | | Foreign-derived deduction eligible income | (4,208) | | | (3.0) | % | | | | | | | | | Other | (142) | | | (0.1) | % | | | | | | | | | | Tax credits | (1,933) | | | (1.4) | % | | | | | | | | | | Nontaxable or nondeductible items | | | | | | | | | | | | | Stock-based compensation | (1,475) | | | (1.0) | % | | | | | | | | | Other | 29 | | | — | % | | | | | | | | | Other (2) | (133) | | | (0.1) | % | | | | | | | | | | Income tax expense | $ | 21,383 | | | 15.1 | % | | | | | | | | |
(1) State taxes in California, Tennessee, Arizona, and Illinois made up the majority of the tax effect in fiscal year 2026. (2) Includes the tax effects of enactment of new tax laws, change in valuation allowance, and change in unrecognized tax benefits. The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes for fiscal years ended January 26, 2025 and January 28, 2024 as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended | | Jan 26, 2025 | | Jan 28, 2024 | | (In millions, except percentages) | | Tax expense computed at federal statutory rate | $ | 17,645 | | | 21.0 | % | | $ | 7,102 | | | 21.0 | % | | Expense (benefit) resulting from: | | | | | | | | | State income taxes, net of federal tax effect | 554 | | | 0.7 | % | | 120 | | | 0.4 | % | | Foreign-derived deduction eligible income | (2,976) | | | (3.5) | % | | (1,408) | | | (4.2) | % | | Stock-based compensation | (2,097) | | | (2.5) | % | | (741) | | | (2.2) | % | | U.S. federal research and development tax credit | (990) | | | (1.2) | % | | (431) | | | (1.3) | % | | Foreign tax rate differential | (984) | | | (1.2) | % | | (467) | | | (1.4) | % | | Other | (6) | | | — | % | | (117) | | | (0.3) | % | Income tax expense | $ | 11,146 | | | 13.3 | % | | $ | 4,058 | | | 12.0 | % |
|
| Schedule of Income Tax Paid |
The amount of cash paid for income taxes (net of refunds) for the fiscal year ended January 25, 2026 is as follows: | | | | | | | | | | | Year Ended | | | Jan 25, 2026 | | | | | | | | | | | | | (In millions) | Federal | $ | 16,755 | | | | | | State | | | | | | California | 1,049 | | | | | | Other | 1,041 | | | | | | Foreign | | | | | | Israel | 1,287 | | | | | | Other | 156 | | | | | | Total income taxes paid, net of refunds | $ | 20,288 | | | | | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: | | | | | | | | | | | | | | Jan 25, 2026 | | Jan 26, 2025 | | | | | | | (In millions) | | Deferred tax assets: | | | Capitalized research and development expenditure | $ | 5,436 | | | $ | 6,256 | | Net controlled foreign corporation tested income deferred tax assets | 5,389 | | | 2,820 | | | Accruals and reserves, not currently deductible for tax purposes | 3,644 | | | 2,058 | | | Research and other tax credit carryforwards | 718 | | | 759 | | | Operating lease liabilities | 554 | | | 299 | | | Net operating loss and capital loss carryforwards | 443 | | | 456 | | | Other deferred tax assets | 679 | | | 566 | | | Gross deferred tax assets | 16,863 | | | 13,214 | | | Less valuation allowance | (768) | | | (1,610) | | | Total deferred tax assets | 16,095 | | | 11,604 | | | Deferred tax liabilities: | | | | | Equity investments | (2,227) | | | (264) | | | Unremitted earnings of foreign subsidiaries | (1,813) | | | (891) | | | Operating lease assets | (533) | | | (286) | | | Acquired intangibles | (38) | | | (70) | | | Gross deferred tax liabilities | (4,611) | | | (1,511) | | | Net deferred tax asset (1) | $ | 11,484 | | | $ | 10,093 | |
(1) Net deferred tax asset includes long-term deferred tax assets of $13.3 billion and $11.0 billion and long-term deferred tax liabilities of $1.8 billion and $886 million for fiscal years 2026 and 2025, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
|
| Schedule of Gross Unrecognized Tax Benefits |
A reconciliation of gross unrecognized tax benefits is as follows: | | | | | | | | | | | | | | | | | | | | Jan 25, 2026 | | Jan 26, 2025 | | Jan 28, 2024 | | | | | | | | | (In millions) | | Balance at beginning of period | $ | 2,861 | | | $ | 1,670 | | | $ | 1,238 | | | Increases in tax positions for current year | 1,959 | | | 1,268 | | | 616 | | | Increases in tax positions for prior years | 57 | | | 48 | | | 87 | | | Lapse in statute of limitations | (224) | | | (27) | | | (19) | | | Decreases in tax positions for prior years | (157) | | | (88) | | | (148) | | | Settlements | (76) | | | (10) | | | (104) | | | Balance at end of period | $ | 4,420 | | | $ | 2,861 | | | $ | 1,670 | |
|